Program Director/Department Chair: Luis Mejico, MD
Epilepsy; Seizures; Epilepsy Surgery; Antiepileptic therapies (medical, surgical and experimental); Functional imaging; Zone state performance; Neuroprotection; Neuromodulation; Neuronal transplantation; Brain stimulation
FMRI and SPECT localization of neuropsychological functions, memory functions and prosody
Painful diabetic neuropathy, Guillain-Barre' syndrome, inflammatory muscle disease.
All forms of sleep disorders, such as narcolepsy and sleep apnea.
CNS acute and chronic polio- and entero-virus infections; Growth factors for Post-Polio Syndrome; Treatment of Multiple Sclerosis; Amyotrophic Lateral Sclerosis (ALS) Motor Neuron Gene Expression
Mechanisms of sensory coding in the olfactory system; seizure mechanisms in hippocampal slices; optical imaging techniques.
My research involves the role of weight gain and recurrence of pseudotumor cerebri. I am also involved at the state and national level for legislative and patient advocacy in the field of neurology.
Multimodality neuromonitoring, advanced neurophysiologic monitoring, intensive insulin therapy for SAH, IV and IA thrombolysis for acute ischemic strokes, Moderate hypothermia
Endovascular strategies to improve outcome in stroke, complex aneurysms and AVM/AVF. Endothelium and blood clot interaction and role of vasodilarot in stroke therapy
Regulation of innate immune responses to viruses.
Clinical reasearch in various Neuro-Ophthalmic conditions such as idiopathic intracranial hypertension; as well as multiple sclerosis and headache syndromes.
Multiple sclerosis and general neurology.
Motor fluctuations and non-motor problems of Parkinson's disease; surgical treatment of Parkinson's disease and other movement disorders; experimental therapies for Parkinson's disease
Clinical Therapeutics of ALS and other motor neuron disorders. Animals models of the physiology and treatment of amyotrophic lateral sclerosis (ALS); Peripheral nerve physiology.
Amyotrophic Lateral Sclerosis